Participants in the Novavax Covid-19 vaccine trial are not yet recognised as being fully vaccinated.
Category Archives: Body Optimization
NHS dentistry access delays: ‘I pulled 11 of my own teeth out’
Dentists warn of waits of up to four years to join an NHS dental practice.
Brain implant may lift most severe depression
Sarah, the first patient to try it, says it has allowed her to enjoy life again.
Sense of touch and heat research wins Nobel Prize
US scientists David Julius and Ardem Patapoutian share the 2021 prize in Physiology or Medicine.
Gene therapy can restore vision after stroke

Most strokes happen when an artery in the brain becomes blocked. Blood flow to the neural tissue stops, and those tissues typically die. Because of the locations of the major arteries in the brain, many strokes affect motor function. Some affect vision, however, causing patients to lose their vision or find it compromised or diminished. A research team led by Purdue University’s Alexander Chubykin, an associate professor of biological sciences in the College of Science, in collaboration with the team led by Gong Chen at Jinan University, China, has discovered a way to use gene therapy to turn glial brain cells into neurons, restoring visual function and offering hope for a way to restore motor function.
Neurons don’t regenerate. The brain can sometimes remap its neural pathways enough to restore some visual function after a stroke, but that process is slow, it’s inefficient, and for some patients, it never happens at all. Stem cell therapy, which can help, relies on finding an immune match and is cumbersome and difficult. This new gene therapy, as demonstrated in a mouse model, is more efficient and much more promising.
“We are directly reprogramming the local glial cells into neurons,” Chubykin said. “We don’t have to implant new cells, so there’s no immunogenic rejection. This process is easier to do than stem cell therapy, and there’s less damage to the brain. We are helping the brain heal itself. We can see the connections between the old neurons and the newly reprogrammed neurons get reestablished. We can watch the mice get their vision back.”
Chubykin’s research is especially important because visual function is easier than motor skills to measure accurately, using techniques including optical imaging in live mice to track the development and maturation of the newly converted neurons over the course of weeks. Perfecting and understanding this technique could lead to a similar technique reestablishing motor function. This research bridges the gap in understanding between the basic interpretation of the neurons and the function of the organs.
make a difference: sponsored opportunity
Story Source:
Materials provided by Purdue University. Original written by Brittany Steff. Note: Content may be edited for style and length.
Journal Reference:
- Yu Tang, Qiuyu Wu, Mang Gao, Esther Ryu, Zifei Pei, Samuel T. Kissinger, Yuchen Chen, Abhinav K. Rao, Zongqin Xiang, Tao Wang, Wen Li, Gong Chen, Alexander A. Chubykin. Restoration of Visual Function and Cortical Connectivity After Ischemic Injury Through NeuroD1-Mediated Gene Therapy. Frontiers in Cell and Developmental Biology, 2021; 9 DOI: 10.3389/fcell.2021.720078
Cite This Page:
Purdue University. “Gene therapy can restore vision after stroke.” ScienceDaily. ScienceDaily, 2 October 2021. <www.sciencedaily.com/releases/2021/10/211002123006.htm>.
Purdue University. (2021, October 2). Gene therapy can restore vision after stroke. ScienceDaily. Retrieved October 3, 2021 from www.sciencedaily.com/releases/2021/10/211002123006.htm
Purdue University. “Gene therapy can restore vision after stroke.” ScienceDaily. www.sciencedaily.com/releases/2021/10/211002123006.htm (accessed October 3, 2021).
Covid: Care home staff should get the jab or another job – Javid
The health secretary says he will not delay the November deadline for workers to be fully vaccinated.
How healthy are vegan ready meals?
Vegan alternatives have never been more widespread, but are they a healthier option?
Covid: Delay of third jabs for most vulnerable criticised
Charities say they have been inundated with calls from worried immunosuppressed people.
Two-dimensional hybrid metal halide device allows control of terahertz emissions

Researchers have utilized two-dimensional hybrid metal halides in a device that allows directional control of terahertz radiation generated by a spintronic scheme. The device has better signal efficiency than conventional terahertz generators, and is thinner, lighter and less expensive to produce.
Terahertz (THz) refers to the part of the electromagnetic spectrum (i.e., frequencies between 100 GHz and 10 THz) between microwave and optical, and THz technologies have shown promise for applications ranging from faster computing and communications to sensitive detection equipment. However, creating reliable THz devices has been challenging due to their size, cost and energy conversion inefficiency.
“Ideally, THz devices of the future should be lightweight, low-cost and robust, but that has been difficult to achieve with current materials,” says Dali Sun, assistant professor of physics at North Carolina State University and co-corresponding author of the work. “In this work, we found that a 2D hybrid metal halide commonly used in solar cells and diodes, in conjunction with spintronics, may meet several of these requirements.”
The 2D hybrid metal halide in question is a popular and commercially available synthetic hybrid semiconductor: butyl ammonium lead iodine. Spintronics refers to controlling the spin of an electron, rather than just using its charge, in order to create energy.
Sun and colleagues from Argonne National Laboratories, the University of North Carolina at Chapel Hill and Oakland University created a device that layered the 2D hybrid metal halides with a ferromagnetic metal, then excited it with a laser, creating an ultrafast spin current that in turn generated THz radiation.
The team found that not only did the 2D hybrid metal halide device outperform larger, heavier and more expensive to produce THz emitters currently in use, they also found that the 2D hybrid metal halide’s properties allowed them to control the direction of the THz transmission.
“Traditional terahertz transmitters were based upon ultrafast photocurrent,” Sun says. “But spintronic-generated emissions produce a wider bandwidth of THz frequency, and the direction of the THz emission can be controlled by modifying the speed of the laser pulse and the direction of the magnetic field, which in turn affects the interaction of magnons, photons, and spins and allows us directional control.”
Sun believes that this work could be a first step in exploring 2D hybrid metal halide materials generally as potentially useful in other spintronic applications.
“The 2D hybrid metal halide-based device used here is smaller and more economical to produce, is robust and works well at higher temperatures,” Sun says. “This suggests that 2D hybrid metal halide materials may prove superior to the current conventional semiconductor materials for THz applications, which require sophisticated deposition approaches that are more susceptible to defects.
“We hope that our research will launch a promising testbed for designing a wide variety of low-dimensional hybrid metal halide materials for future solution-based spintronic and spin-optoelectronic applications.”
The work appears in Nature Communications and is supported by the National Science Foundation under grant ECCS-1933297. Postdoctoral researcher Kankan Cong of Argonne National Laboratory, former NC State graduate student Eric Vetter of North Carolina State University, and postdoctoral researcher Liang Yan of UNC-CH are co-first authors. Haiden Wen, physicist at Argonne National Laboratory, Wei You, professor of chemistry at UNC-CH and Wei Zhang, associate professor at Oakland University, are co-corresponding authors of the research.
Story Source:
Materials provided by North Carolina State University. Original written by Tracey Peake. Note: Content may be edited for style and length.
Covid antiviral pill can halve risk of hospitalisation
Promising results mean a clinical trial has ended early and emergency authorisation is being sought.
